Jabil Healthcare Signs Strategic Collaboration Agreement with E3D, Expanding Pharmaceutical Market Offering

ST. PETERSBURG, Fla.–(BUSINESS WIRE)–Jabil Healthcare, a division of Jabil Inc. (NYSE: JBL), today announced it has entered a strategic collaboration agreement with global drug delivery device company E3D, a member of the Elcam Medical Group, which gives Jabil access to E3D’s reusable mechanical auto-injector. Under the terms of this deal, Jabil has secured exclusive rights to develop a high-volume reusable auto-injector and connected variants.
The agreement enables Jabil Healthcare to further develop connected auto-injectors for a range of dosing volumes and patient-centric benefits, ultimately creating a platform of devices. Jabil Healthcare applies its expertise to help customers through the design, development and…